A Pipeline Teeming with Innovation Beyond todays leading therapies like Mounjaro, Zepbound, Ozempic, and Wegovy, a robust pipeline of next-generation obesity drugs is advancing through clinical development, with several candidates already filed for regulatory approval
Davogustto GE, Clark DE, Hardison E, Yanis AH, Lowery BD, Halasa NB, et al
Once you meet your deductible, you'll typically pay a fixed percent of the drug's cost, called coinsurance, until you meet your annual spending cap, called an out of pocket maximum
Polymorphisms and a rare missense mutation that impair CaMKK2 function are associated with bipolar disorder Whole exome sequencing and genetic association studies have uncovered a link between bipolar disorder and loss-of-function polymorphisms and mutations in human CAMKK2
Understanding Medi-Cal Coverage and Employment Changes to your employment status may impact your income, but having a job does not automatically affect your Medi-Cal eligibility
Siddiqui, A